News
5 June 2014
Major phase III cognitive trial to use Cantab assessment technology
Cambridge Cognition announces the signing of a significant contract for a global multi-year study in which Cantab Solutions technology will be used to assess the cognitive safety of a new medicine under development.
Read on
3 June 2014
Cognitive safety assessment products launched on Cantab Connect
Rapid tablet-based assessment paves the way for faster and more accurate decision making on cognitive safety and abuse potential of drug treatments.
Read on
1 June 2014
You’re invited to our get-together at the Varsity Hotel on July 21st
You are invited to a free drinks and canapé get-together hosted by Cambridge Cognition.
Read on
28 May 2014
North East Lincolnshire CCG to improve dementia diagnosis rates with Cantab Mobile
North East Lincolnshire Clinical Commissioning Group has introduced the Cantab Mobile iPad app into 11 sites across the region in an attempt to improve dementia diagnosis rates.
Read on
27 May 2014
Cambridge researchers ‘excited’ by double scientific breakthrough in Alzheimer’s and Parkinson’s
Cambridge University researchers have announced two scientific breakthroughs which could improve future treatment of diseases such as Alzheimer’s and Parkinson’s.
Read on
23 May 2014
Depression does not impact on cognition in early bipolar disorder
New research suggests that depressive episodes have no additional impact on cognition in patients early in the course of bipolar disorder.
